Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV nicardipine pharmacokinetics and pharmacodynamics in severe hypertension during preeclampsia
2012-005330-10Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nicardipine in preeclampsia and maternal hypertension (HDP), sponsored by Erasmus MC. Primary endpoints: Maternal nicardipine half-life parameters and Maternal hemodynamic changes after nicardipine. Started Mar 2013; status: active.
02
Drugs
nicardipine
03
Conditions
preeclampsiamaternal hypertension (HDP)
Beyond the preview
Go deeper on 2012-005330-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005330-10.